| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/10/2001 | US6214824 Synergistic mixture with hydrochlorothiazide |
| 04/10/2001 | US6214822 Substituted aza and diazacycloheptane and cyclooctane compounds and their use |
| 04/10/2001 | US6214821 Methods and composition for the inhibition of cancer cells |
| 04/10/2001 | US6214819 Method for treating ocular neovascular diseases |
| 04/10/2001 | US6214817 Nitrogen macrocycle complexes with manganese and iron |
| 04/10/2001 | US6214815 Triphasic oral contraceptive |
| 04/10/2001 | US6214814 Use of betulinic acid derivatives for inhibiting cancer growth |
| 04/10/2001 | US6214813 Azopyrazoles |
| 04/10/2001 | US6214812 Vitamin b6 bisphosphonate conjugate |
| 04/10/2001 | US6214811 Viricides and prodrugs |
| 04/10/2001 | US6214810 Methods of treating or preventing cardiac arrhythmia |
| 04/10/2001 | US6214809 Methods of treating or preventing cardiac arrhythmia |
| 04/10/2001 | US6214808 Hemostatic agent |
| 04/10/2001 | US6214807 Images and cardiovascular disorders |
| 04/10/2001 | US6214806 Use of nucleic acids containing unmethylated CPC dinucleotide in the treatment of LPS-associated disorders |
| 04/10/2001 | US6214805 Genes, gene signals, genomes rna strands and respiratory syncytial virus with promoters |
| 04/10/2001 | US6214803 Pharmacological composition for treating cancer cells |
| 04/10/2001 | US6214801 Imidazo[1,2-a]pyridine C-nucleosides as antiviral agents |
| 04/10/2001 | US6214796 Administering a polypeptide growth factor for improved sensor motor deficit caused by injury |
| 04/10/2001 | US6214792 Administering octreotide and anticholinergic agent |
| 04/10/2001 | US6214600 Polypeptide of defined amino acid sequence; treatment of alzheimer's disease, stroke, musculoskeletal disease, heart disease, kidney disease; anticarcinogenic/antiinflammatory agents; antiarthritic agents; diagnosis |
| 04/10/2001 | US6214595 Enzymatic polypeptide for utilization in screening bactericides; wound healing agents; for prevent of bacterial wound infections |
| 04/10/2001 | US6214543 DNA molecule encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 04/10/2001 | US6214540 Chemokines that inhibit immunodeficiency virus infection and methods based thereon |
| 04/10/2001 | US6214536 Method of detecting lung disease |
| 04/10/2001 | US6214388 Immunoliposomes that optimize internalization into target cells |
| 04/10/2001 | US6214387 Biodegradable polymer matrices for sustained delivery of local anesthetic agents |
| 04/10/2001 | US6214385 Controlled absorption diltiazem pharmaceutical formulation |
| 04/10/2001 | US6214381 Methazolamide composition and method of use |
| 04/10/2001 | US6214379 Useful for adaptation to schedules, cycles and needs of individuals improving compliance with their therapy, reducing amounts required daily to less than conventionally utilized, and minimizing undesired effects; drug delivery |
| 04/10/2001 | US6214360 Pharmaceutical composition |
| 04/10/2001 | US6214359 Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant Streptococcus pneumoniae |
| 04/10/2001 | US6214355 DbpA compositions |
| 04/10/2001 | US6214348 Administering to the mammal a polypeptide comprising seq id no:2 in an amount sufficient to induce an immunological response to produce antibodies to seq id no:2 |
| 04/10/2001 | US6214346 Bactericides |
| 04/10/2001 | US6214345 Lysosomal enzyme-cleavable antitumor drug conjugates |
| 04/10/2001 | US6214342 Method for increasing mean survival times of transplants with LFA-1-specific antibodies |
| 04/10/2001 | US6214337 Animal feeds comprising yeast glucan |
| 04/10/2001 | US6214332 Applying a composition of a polymerizable cyanoacrylate ester, and an antimicrobially effective amount of a complex of iodine molecules with a biocompatible polymer, and polymerizing to join separated skin sections together |
| 04/10/2001 | US6214330 Polymeric-based double prodrugs having reversible linkages involving amino or hydroxyl moieties of chemical compounds and biologically active materials such as enzymes and proteins |
| 04/10/2001 | US6214327 Antibacterial composition |
| 04/10/2001 | US6214325 Improving smoothness, combing and/or disentangling of hair |
| 04/10/2001 | US6214318 Comprising mineral oils, vegetable oils, silicone oils or synthetic oils; thickening agents such as waxes to thicken oils to non-flowable state; optionally adjuvants, drugs and emulsifiers and a liquefied propellant; cooling effect |
| 04/10/2001 | CA2251636C Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle |
| 04/10/2001 | CA2222299C Novel taxoids |
| 04/10/2001 | CA2210749C Anti-inflammatory eye drop |
| 04/10/2001 | CA2200604C Novel production intermediate and process for producing pyridine derivative |
| 04/10/2001 | CA2165618C Tricyclic oxime ethers; process for preparing the same and pharmaceutical compositions containing them |
| 04/10/2001 | CA2162106C 5-(aryloxymethyl)oxazolines, process for preparing the same and pharmaceutical compositions containing them |
| 04/10/2001 | CA2133413C Indole derivatives as 5-ht1 antagonists |
| 04/10/2001 | CA2119661C New n-benzylpiperazine compounds, their preparation process and pharmaceutical compositions containing them |
| 04/10/2001 | CA2117532C Method of inhibiting carcinogenesis by treatment with dehydropiandrosterone and analogs thereof |
| 04/10/2001 | CA2086974C R(+)-terazosin |
| 04/10/2001 | CA2059263C Composition comprising the (-) enantiomer of cis-4-amino-1-(2-hydromethyl-1,3-oxathiolan-5-yl)-(1h)-pyrimidine-2-one or an enriched composition thereof, and its uses as a pharmaceutical agent |
| 04/10/2001 | CA2056412C Discodermolide compounds, compositions containing same and methods of preparation and use |
| 04/10/2001 | CA2027608C Hair revitalizing agent |
| 04/10/2001 | CA2019410C Liquid polymer composition, and method of use |
| 04/07/2001 | CA2320400A1 Gene necessary for striatal function and uses thereof, and compounds for modulating same |
| 04/07/2001 | CA2285690A1 Gene necessary for striatal function and uses thereof |
| 04/06/2001 | CA2322560A1 Corticoid therapy |
| 04/05/2001 | WO2001023604A2 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 04/05/2001 | WO2001023590A2 22196, a novel human aminopeptidase |
| 04/05/2001 | WO2001023588A1 Human carboxypeptidases and polynucleotides encoding the same |
| 04/05/2001 | WO2001023584A1 Human ubiquitin protease |
| 04/05/2001 | WO2001023565A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 04/05/2001 | WO2001023551A1 Novel nicotinic acetylcholine receptor subunit, its isolation and use |
| 04/05/2001 | WO2001023550A2 Pca3 messenger rna species in benign and malignant prostate tissues |
| 04/05/2001 | WO2001023540A2 P-glycoproteins and uses thereof |
| 04/05/2001 | WO2001023409A2 38 human secreted proteins |
| 04/05/2001 | WO2001023408A1 5-hydroxysapogenin derivatives with anti-dementia activity |
| 04/05/2001 | WO2001023407A1 Sapogenin derivatives and their use in the treatment of cognitive dysfunction |
| 04/05/2001 | WO2001023406A1 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 04/05/2001 | WO2001023405A2 Therapeutic treatment of androgen receptor driven conditions |
| 04/05/2001 | WO2001023399A1 Compounds for the treatment of ischemia |
| 04/05/2001 | WO2001023398A1 Novel fucosylated oligosaccharides and process for their preparation |
| 04/05/2001 | WO2001023390A2 Azepinoindole derivatives, the production and use thereof |
| 04/05/2001 | WO2001023389A2 Certain alkylene diamine-substituted heterocycles |
| 04/05/2001 | WO2001023388A2 AMINO SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES |
| 04/05/2001 | WO2001023387A2 CERTAIN ALKYLENE DIAMINE-SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES |
| 04/05/2001 | WO2001023386A2 Benzodiazepin derivatives, the production and use thereof |
| 04/05/2001 | WO2001023385A2 Novel tropane analogs |
| 04/05/2001 | WO2001023384A1 Antitumor agents |
| 04/05/2001 | WO2001023383A1 Quinuclidine compounds and drugs containing the same as the active ingredient |
| 04/05/2001 | WO2001023382A1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 04/05/2001 | WO2001023381A1 Piperidine derivatives as reuptake inhibitors |
| 04/05/2001 | WO2001023380A1 Piperidine derivatives as serotonine reuptake inhibitors |
| 04/05/2001 | WO2001023379A1 Pharmaceutically active sulfonyl amino acid derivatives |
| 04/05/2001 | WO2001023378A1 Pharmaceutically active sulfonamide derivatives |
| 04/05/2001 | WO2001023377A2 Polymorphic salt |
| 04/05/2001 | WO2001023376A1 Isonipecotamides for the treatment of integrin-mediated disorders |
| 04/05/2001 | WO2001023375A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 04/05/2001 | WO2001023374A1 Piperazine derivatives as 5-ht1b antagonists |
| 04/05/2001 | WO2001023372A1 Anti-drug resistant strain agents and antichlamydia agents |
| 04/05/2001 | WO2001023366A2 Vasopressin antagonist and diuretic combination |
| 04/05/2001 | WO2001023362A2 Rate-controlled particles |
| 04/05/2001 | WO2001023360A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 04/05/2001 | WO2001023359A1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors |
| 04/05/2001 | WO2001023357A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/05/2001 | WO2001023347A1 Novel aromatic compounds |
| 04/05/2001 | WO2001023000A1 Coating preparations soluble in lower digestive tract |